AZALEA (Clearside Biomedical)A phase 3, open-label safety study of suprachoroidal triamcinolone acetonide injectable suspension in patients with non-infectious uveitis.
DOGWOOD (Clearside)A phase 2, 6 month, randomized, masked, multicenter study to assess the safety and efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the treatment of subjects with macular edema following uveitis.
LUMINA 010906IN (Santen)
A Phase 3, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ìg DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.
LX211-11 (LUX BIOSCIENCE)
Phase 3 study of the efficacy and safety of voclosporin for non-infectious uveitis.
MAGNOLIA (Clearside Biomedical)A multicenter, non-interventional extension study of the safety and efficacy of CLS-TA for the treatment of macular edema associated with non-infectious uveitis.
PEACHTREE (Clearside Biomedical)A 6 month, phase 3, randomized, masked, controlled clinical trial to study the safety and efficacy and safety of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the treatment of subjects with Macular Edema associated with Non-Infectious Uveitis.
A 2 year Phase 3 active treatment controlled study assessing the efficacy and safety of Sirolimus for the treatment of non-infectious uveitis.
TAHOE (NCRVA and Allergan)
A 6 month Prospective study of the Dexamethasone Intravitreal Implant (Ozurdex) for Uveitic Macular Edema.
The use of a sustained-release ganciclovir implant to treat Cytomegalovirus Retinitis.